BIOLASE, Inc. (BIOL)

BIOLASE Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.39	6.57	4.18	29.97	17.56	5.79
Cash & Cash Equivalents	6.39	6.57	4.18	29.97	17.56	5.79
Cash Growth	-2.13%	57.04%	-86.05%	70.64%	203.40%	-28.03%
Receivables	5.69	5.48	5.84	4.24	3.06	8.76
Inventory	11.27	11.43	15.88	12.93	11.16	11
Other Current Assets	1.65	1.38	3.05	2.22	3.33	1.48
Total Current Assets	25.01	24.86	28.96	49.35	35.11	27.02
Property, Plant & Equipment	6.16	7.04	6.05	2.78	2.76	1.47
Long-Term Investments	0	0	0	0	0	-0.08
Goodwill	11.7	2.93	2.93	2.93	2.93	2.93
Other Long-Term Assets	0.26	0.27	0.26	0.22	0.23	0.51
Total Long-Term Assets	9.35	10.24	9.23	5.93	5.92	4.83
Total Assets	34.35	35.1	38.19	55.28	41.03	31.85
Accounts Payable	4.92	6.07	5.79	3.31	2.65	5.33
Deferred Revenue	2.34	2.45	2.11	2.26	1.91	2.24
Current Debt	3.7	3.15	0.7	0.41	0.31	13.47
Other Current Liabilities	10.47	7.99	9.21	7.87	6.36	4.74
Total Current Liabilities	21.43	19.66	17.81	13.84	11.22	25.78
Long-Term Debt	13.41	13.99	14.35	15.05	17.96	4.21
Other Long-Term Liabilities	1.45	1.7	1.14	1.18	1.81	1.48
Total Long-Term Liabilities	14.86	15.68	15.49	16.23	19.77	5.69
Total Liabilities	36.29	35.35	33.3	30.08	31	31.47
Total Debt	17.66	17.91	15.05	15.05	17.96	13.47
Debt Growth	9.67%	19.00%	-0.01%	-16.19%	33.37%	24.27%
Common Stock	0.03	0	0.01	0.15	0.1	0.03
Retained Earnings	-323.29	-316.8	-296.17	-267.53	-251.38	-234.55
Comprehensive Income	-0.64	-0.55	-0.73	-0.62	-0.39	-0.7
Shareholders' Equity	-1.93	-0.25	4.89	25.21	10.03	0.38
Total Liabilities and Equity	34.35	35.1	38.19	55.28	41.03	31.85
Net Cash / Debt	-11.26	-11.34	-10.87	14.92	-0.4	-7.68
Net Cash Per Share	-0.63	-8.88	-156.84	252.46	-16.19	-827.23
Working Capital	3.58	5.2	11.15	35.51	23.89	1.24
Book Value Per Share	-0.11	-0.19	70.55	426.55	410.08	40.62

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.